Global Liver Cirrhosis Market By Overview
Prophecy Market Insights has recently published its insights on “Global Liver Cirrhosis Market” for the forecast period of 2018-2029.
Rise in the prevalence of liver disease is the major driving factor for the target market growth. Also, rapid changing lifestyle such as increase in alcohol consumption is boosting the target market growth. In addition, increase in the awareness programs regarding liver cirrhosis is fuelling the target market growth. Furthermore, rise in research & development investment for the development of new drug therapyare anticipated to augment the global liver cirrhosis market in the forecast period. However, high cost of drug development in terms of liver cirrhosis is the major restrain for the target market growth.
North America to grow at the highest CAGR during the forecast period
North America is expected to be the dominating target market and is expected to continue dominating the target market over the forecast period due to favorable reimbursement scenario and higher health care spending. Whereas, Europe is anticipated to be the second leading target market. Rise in awareness about new treatment options and developed regulatory framework is the major factor boosting the target market in the region. Asia-Pacific is expected to show a significant growth in the forecast period owing to rise in prevalence of liver disease and improving health care infrastructure.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global liver cirrhosis market report segments the market on the basis of types, applications, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global liver cirrhosis market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Competitive Analysis
Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global automotive composites market. Key players have adopted mergers & acquisitions and new product developments to strengthen their positions in the global liver cirrhosis market. For instance, in April, 2019, Gilead Sciences introduced new grant programs supporting investigator sponsored research in liver diseases.
- F Hoffman La-Roche AG
- GlaxoSmithKline LLC
- Intercept Pharmaceuticals
- Johnson & Johnson SA
- Gilead Sciences., Inc.
- Merck & Co., Inc.
- Bristol-Myers Squibb Co.
- Conatus Pharmaceuticals., Inc.
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Instituto Grifols SA
Prophecy Market Insights offers required customization on this report according to specific business requirements.
Global Liver Cirrhosis Market By Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Types
- Market Snippet, By Applications
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Liver Cirrhosis Market, By Types, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Alcoholic Cirrhosis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Atrophic Cirrhosis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Biliary Cirrhosis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cryptogenic Cirrhosis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Cardiac Cirrhosis
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Liver Cirrhosis Market, By Applications, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Specialty Clinics
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Hospitals
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Liver Cirrhosis Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Types, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Applications, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Types, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Applications, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Types, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Applications, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Types, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Applications, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Types, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By By Applications, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- F Hoffman La-Roche AG
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- GlaxoSmithKline LLC
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Intercept Pharmaceuticals
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Johnson & Johnson SA
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Gilead Sciences., Inc.
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co., Inc.
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bristol-Myers Squibb Co.
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Conatus Pharmaceuticals., Inc.
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Gwo Xi Stem Cell Applied Technology Co., Ltd.
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Instituto Grifols SA
- Company Overview
- Types Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The liver cirrhosis market report segments the market on the basis of types, applications, and region.
The development of novel therapeutic approaches for liver cirrhosis, the increasing focus on early diagnosis and intervention, and the exploration of regenerative medicine and advanced therapies, presenting significant opportunities in the global Liver Cirrhosis Market.
Rising incidence of liver diseases leading to cirrhosis, advancements in diagnostic technologies, the demand for effective pharmacological and surgical treatments, and the global efforts to address the burden of liver-related disorders.
Asia-Pacific is expected to dominate the Liver Cirrhosis Market, driven by a high prevalence of liver diseases, including viral hepatitis, and significant efforts to improve healthcare infrastructure in the region.
F Hoffman La-Roche AG, GlaxoSmithKline LLC, Intercept Pharmaceuticals, Johnson & Johnson SA, Gilead Sciences., Inc., Merck & Co., Inc., Bristol-Myers Squibb Co., Conatus Pharmaceuticals., Inc., Gwo Xi Stem Cell Applied Technology Co., Ltd., Instituto Grifols SA,